Rachel Goodwin

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

Stephanie Yasmin Brule, Derek J. Jonker, Christos S. Karapetis et al. · European Journal of Cancer · 2015 · 333 citations

Gastrointestinal Oncology, Prognostic Factor, Medicine +12

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Lawrence Fong, Andrew Hotson, John D. Powderly et al. · Cancer Discovery · 2019 · 321 citations · Full text

Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study

Funda Meric‐Bernstam, Muralidhar Beeram, Erika Hamilton et al. · The Lancet Oncology · 2022 · 164 citations · Full text

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

John Hilton, Karen A. Gelmon, Philippe L. Bédard et al. · Nature Communications · 2022 · 128 citations · Full text

Overview of Systemic Therapy for Colorectal Cancer

Rachel Goodwin, Timothy R. Asmis · Clinics in Colon and Rectal Surgery · 2009 · 76 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +11